Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Friday, October 30, 2026

Back to the front page

From X

@MultiplesCap

Multiples Capital on X

$EXPE has always been a much slower grower than $BKNG, won't be surprised if it's a fav pair trade of hedge fund (long booking, short expe). Over the years though Expedia has been going through internal changes, sold some businesses (Egencia to AmEx travel and few other sites), went through a technology transformation for internal sites (Expedia, https://t.co/ap3OIandej, Vrbo). 50% improvement in operating margin since 2019. But not as profitable as Booking (operating margin at 12% vs 32% for bkng). Mainly a US focused player (unlike bkng) with a very strong B2B segment that's growing mid teens and about 30% of total revenue), now looking to expand internationally. To be seen if that would drive higher margin given the much fragmented hotel market internationally vs US. Bkng on the other hand seeing revenue growth slowing down to high single digit and mid teens eps growth with margins declining since 2019. Expedia needs to show higher top line growth but possible still delivers mid teens eps growth. Travel is cyclical but these OTA are very robust, they saw revenue growth even in the financial crisis, as more ppl look for deals. AI is an unknown, Expedia is embracing it. Finding a hotel with the right deal is not same as getting an answer to a question from LLM, distribution/platform should remain valuable. Interesting to see how the pieces fall for Expedia, PEG < 1 and these multiples should atleast provide downside protection
@HaydenCapital 1 click

Fred Liu on X

Loved this interview with Adam at Applovin $APP. Insight into his strategic thinking + the story of building a $100BN firm with almost 0 funding (just $4M total). And his decision of buying back ~25% of shares at rock-bottom prices, contributing to their massive stock performance since 2023. https://t.co/2We2q8sG8n ** My favorite quotes: "We went public in April 21. And if I remember right, by December lockups free from January 22 to December 22, I think our stock went down like 92%. Um, it was red every day. And so that it ends up setting you up for failure. Now we were really fortunate because of how we started. We were always cashflow positive. So I controlled our own destiny. We were generating, I think it was a billion dollars of EBITDA. And at the low point, I think we got to a market cap of $4 billion. And so if you think about like cash yield return, it's over 20%. It's really cheap. You could manage and buy out a company at that level with just debt. And so what we did at the low point was we buckled down, said, we've all been here a long time. Let's build really great products. That's how we're going to recover. no one's going to buy our stock at this point. There's no narrative to sell. Everyone's gone. So let's buy our own shares. And we ended up issuing a lot of stock to the team, putting in a performance equity plan, and then becoming the biggest buyer of our own shares over the next year. And so we went from bottom $9 to peak $522 years later. A large part of that, I would say, probably 20-25% of that appreciation was because we bought back 20-25% of the cap table at very low prices because we could." ** And he refuses to speak to the Pods: "And then you realize I also want to recruit investors who believe in what I'm building over time, not who are betting on the stock for a quarter. And so I ended up changing investor relations and I don't take meetings with anyone who's who's focused on what's happening next quarter in a business as robust as ours. What's happening next quarter is defined by things we did a year ago. What's happening in three to five years is what I'm focused on. And so I only spend time with people who want to align with my vision long term. And that creates a much more engaging perspective on the world and got me to start thinking about the business exactly the same way as I did when we were private. And I still operate it today that way."

Investor Letters

All letters

SNY Earnings Review

Sanofi raised FY26 guidance after Q3 sales grew 14.3% at constant currency, led by 34.8% Dupixent growth; vaccines declined 6.6%.

SNY $114B
Cestrian Capital Research 1 click

AMZN Q3 FY12/26 Earnings Review

Amazon reported $201.9 billion Q3 revenue and 39% AWS growth, while $220 billion in 2026 capex drove trailing free cash flow to a $42.4…

AMZN $2.9T
Cestrian Capital Research 3 clicks
SAP · long

Sap Se

SAP shares are down 45% since February 2025 as AI disruption fears create a long thesis on its risk-reward.

SAP $277B
Value Investors Club 2 clicks

Another Haircut with Avy the Barber

SoFi’s stock case hinges on interest rates, tangible book value and private-credit loan sales after its $1.5 billion equity offering.

SOFI $21B
WHAT ARE WE DOING? “Contrarians At The Gate” 3 clicks

Intel Q3 2026: Dead Inside

Intel’s Q3 2026 datacenter CPU shortage reflects wafer-start planning failures, not substrate constraints, after demand shifted from client…

INTC $287B
Irrational Analysis 2 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 74 of 277

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

359 firms

Sectors

Ordered by how often our editor reaches for them.